Early 2022, the European Journal of Allergy and Clinical Immunology published the 2021 revision and update of the international WAO/EAACI guideline for the management of HAE.
The updated guideline reflects consensus among an international panel of 60 HAE experts, and includes 28 recommendations that provide physicians and patients with guidance on important clinical issues, such as: (1) How should HAE be diagnosed? (2) When should HAE patients receive prophylactic on top of on-demand treatment, and what treatments should be used? (3) What are the goals of treatment? (4) Should HAE management be different for special HAE patient groups such as children or pregnant/breastfeeding women? and (5) How should HAE patients monitor their disease activity, impact, and control?
>> Read more about the 28 recommendations
>> View the international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update